Growth Metrics

Zymeworks (ZYME) Long-Term Deferred Tax (2021 - 2026)

Zymeworks recorded quarterly Long-Term Deferred Tax of $4.7 million in Q1 2026, little changed quarter-over-quarter from $4.7 million in Q4 2025, and down 2.93% year-over-year from $4.8 million in Q1 2025.

Zymeworks' Long-Term Deferred Tax history runs 6 years deep, the most recent figure standing at $4.7 million for Q1 2026.

  • In Q1 2026, Long-Term Deferred Tax fell 2.93% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (down 2.93% YoY), while the FY2025 annual figure was $4.7 million, up 7.34% from the prior year.
  • Long-Term Deferred Tax came in at $4.7 million for Q1 2026 at Zymeworks, roughly flat from $4.7 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $4.9 million in Q3 2025 to a low of $1.3 million in Q3 2023.
  • A 5-year average of $3.5 million and a median of $3.9 million in 2024 frame the typical range for Long-Term Deferred Tax.
  • Across the five-year window, Long-Term Deferred Tax plunged 56.57% in 2023 and soared 219.85% in 2024, its largest moves.
  • Zymeworks' Long-Term Deferred Tax stood at $1.3 million in 2022, then soared by 168.77% to $3.6 million in 2023, then advanced by 21.3% to $4.4 million in 2024, then grew by 7.34% to $4.7 million in 2025, then changed by 0.0% to $4.7 million in 2026.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $4.7 million, $4.7 million, and $4.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Zymeworks 1.84 Bn 1.47 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.71 Mn
Dec 31, 2025 4.71 Mn
Sep 30, 2025 4.86 Mn
Jun 30, 2025 4.77 Mn
Mar 31, 2025 4.85 Mn
Dec 31, 2024 4.39 Mn
Sep 30, 2024 4.21 Mn
Jun 30, 2024 3.95 Mn
Mar 31, 2024 3.70 Mn
Dec 31, 2023 3.62 Mn
Sep 30, 2023 1.32 Mn
Jun 30, 2023 1.36 Mn
Mar 31, 2023 1.41 Mn
Dec 31, 2022 1.35 Mn
Sep 30, 2022 3.03 Mn
Dec 31, 2021 3.07 Mn